美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Jyong Biotech Ltd. (Revived IPO)

成交量：- -

成交額：- -

市值：- -

市盈率：- -

高：- -

開：- -

低：- -

收：- -

資料載入中...

總覽公司新聞公告

公司資料

公司名字：

Jyong Biotech Ltd. (Revived IPO)

交易所：

NASDAQ

成立時間：

- -

員工人數：

- -

公司地址：

- -

官網：

http://www.healtheverbiotech.com

郵編：

- -

電話：

- -

傳真：

- -

簡介：

Jyong Biotech Ltd.是一家於2018年1月26日註冊成立的開曼群島豁免公司，主要通過在中國台灣的全資子公司開展業務。健永生技於2002年7月通過Health Ever Bio-Tech Co., Ltd.開始商業運營，該公司自2018年8月以來一直由Jyong Biotech Ltd.全資擁有。健永生技是一家科學驅動型生物技術公司，總部位於中國台灣，致力於開發和商業化創新和差異化新藥（植物衍生），主要專註於泌尿系統疾病的治療，最初的重點是美國、歐盟和亞洲市場。

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/MENS/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MENS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MENS\",,,,,undefined,":{"symbol":"MENS","market":"US","secType":"STK","nameCN":"Jyong Biotech Ltd. (Revived IPO)","latestPrice":0,"timestamp":1748980800000,"preClose":0,"halted":9,"volume":0,"delay":0,"floatShares":2666667,"shares":76027667,"eps":0,"marketStatus":"已收盤","change":0,"latestTime":"06-03 16:00:00 EDT","open":0,"high":0,"low":0,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1749024000000},"marketStatusCode":5,"adr":0,"listingDate":1744862400000,"exchange":"NASDAQ","adjPreClose":0,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MENS\",,,,,undefined,":{"symbol":"MENS","floatShares":2666667,"roa":"-17.59%","roe":"--","lyrEps":0,"shares":76027667,"dividePrice":0,"high":0,"amplitude":0,"preClose":0,"low":0,"week52Low":0,"pbRate":"0.00","week52High":0,"institutionHeld":0,"latestPrice":0,"eps":0,"divideRate":0,"volume":0,"delay":0,"ttmEps":0,"open":0},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.healtheverbiotech.com","compareEarnings":[{"period":"1week","weight":0.0235},{"period":"1month","weight":0.0458},{"period":"3month","weight":0.0275},{"period":"6month","weight":-0.0246},{"period":"1year","weight":0.1239},{"period":"ytd","weight":0.0113}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Jyong Biotech Ltd.是一家於2018年1月26日註冊成立的開曼群島豁免公司，主要通過在中國台灣的全資子公司開展業務。健永生技於2002年7月通過Health Ever Bio-Tech Co., Ltd.開始商業運營，該公司自2018年8月以來一直由Jyong Biotech Ltd.全資擁有。健永生技是一家科學驅動型生物技術公司，總部位於中國台灣，致力於開發和商業化創新和差異化新藥（植物衍生），主要專註於泌尿系統疾病的治療，最初的重點是美國、歐盟和亞洲市場。","exchange":"NASDAQ","name":"Jyong Biotech Ltd. (Revived IPO)","nameEN":"Jyong Biotech Ltd. (Revived IPO)"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"MENS\",market:\"US\",,,undefined,":null,"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MENS\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MENS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MENS\",market:\"US\",delay:false,,,undefined,":{}}}